<SEC-DOCUMENT>0000950170-24-060796-index.html : 20240516
<SEC-HEADER>0000950170-24-060796.hdr.sgml : 20240516
<ACCEPTANCE-DATETIME>20240516073021
ACCESSION NUMBER:		0000950170-24-060796
CONFORMED SUBMISSION TYPE:	ARS
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20240516
DATE AS OF CHANGE:		20240516
EFFECTIVENESS DATE:		20240516

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cullinan Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001789972
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				813867811
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		ARS
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39856
		FILM NUMBER:		24953563

	BUSINESS ADDRESS:	
		STREET 1:		ONE MAIN STREET
		STREET 2:		SUITE 1350
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		617-410-4650

	MAIL ADDRESS:	
		STREET 1:		ONE MAIN STREET
		STREET 2:		SUITE 1350
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cullinan Oncology, Inc.
		DATE OF NAME CHANGE:	20210225

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cullinan Management, Inc.
		DATE OF NAME CHANGE:	20210107

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cullinan Oncology, LLC
		DATE OF NAME CHANGE:	20191001
</SEC-HEADER>
<DOCUMENT>
<TYPE>ARS
<SEQUENCE>1
<FILENAME>2023_annual_report.pdf
<DESCRIPTION>ARS
<TEXT>
Document 1 - file: 2023_annual_report.pdf

</DOCUMENT>
</SEC-DOCUMENT>